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Currently, there is no eﬀective treatment for the marked neuronal loss caused by neurodegenerative diseases, such as Huntington’s
disease (HD) orischemic stroke. However, recent studies have shownthat new neuronsare continuously generated by endogenous
neural stem cells in the subventricular zone (SVZ) of the adult mammalian brain, including the human brain. Because some of
thesenew neuronsmigrate to the injured striatum anddiﬀerentiate into mature neurons, such new neurons may be able to replace
degenerated neurons and improve or repair neurological deﬁcits. To establish a neuroregenerative therapy using this endogenous
system,endogenousregulatorymechanismsthatcanbe co-optedforeﬃcientregenerative interventionsmustbeunderstood,along
with any potential drawbacks.Here, we review current knowledge on the generation ofnew neurons in the adult brain and discuss
their potential for use in replacing striatal neurons lost to neurodegenerative diseases, including HD, and to ischemic stroke.
1.Introduction
Huntington’s disease (HD) is an adult-onset autosomal-
dominant inherited neurodegenerative disorder with pro-
gressive symptoms that include involuntary movements,
cognitivedeﬁcits,andvariouspsychiatric disturbances[1–3].
HD is caused by an expanded CAG repeat in the huntingtin
gene [4–6]. The expanded CAG repeat givesrise to an abnor-
mally long polyglutamine stretch in the mutant huntingtin,
which is toxic to neurons in the striatum and frontal cortex
[7]. The most striking pathophysiology of HD is the pro-
gressive degeneration of projection neurons and heightened
gliosis, leading to a marked atrophy of the striatum and
cerebral cortex [8]. So far, although potential therapeutic
interventions aimed at suppressing the production of the
mutant huntingtin protein and reducing its toxicity have
been aggressively pursued [9–13], no eﬀective treatment for
HDhasbeendeveloped.Oﬀeringhope,however,areﬁndings
by recent studies suggesting that the adult brain’s capacity to
generate new neurons may be a resource for replacing the
aﬀected neurons with newly generated ones.
In the mammalian brain, the subventricular zone (SVZ),
which is a thin cell layer in the lateral walls of lateral
ventricles, continues to produce new neurons during adult-
hood. Postmortem analyses have shown that the SVZ in
HD patients is thickened by increased cell proliferation
[14, 15]. In addition, in an HD transgenic mouse model,
R6/2 mice carrying the human HD gene with long CAG
repeats [16] generate new neurons in the SVZ that migrate
into the aﬀected striatum and diﬀerentiate into mature
neurons. Unfortunately, although these alterations may
reﬂect protective responses provoked by the progressive
degeneration of striatal neurons owing to HD, they are
insuﬃcient to compensate for the pathological process.
Nonetheless, these observations may signal the possibility
of future interventions that promote the production and
migration of new neurons to the damaged striatum and
improve the neurological impairments of this disease and/or
stop its progression. Here, we review current knowledge
on the generation of new neurons (neurogenesis) in the
adult brain and discuss its potential for replacing neurons
damaged by pathological conditions, including HD.2 Neurology Research International
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Figure 1:Neurogenesis in theadultbrain.(a)Schematicdrawingofadultrodent brain showingthetwo regions,theSVZ andtheDG, where
new neurons are continuously generated. (b) Location and structure of the SVZ. The SVZ consists of four types of cells, ependymal cells
(purple), neural stem cells (blue), transit-amplifying cells (green), and new neurons (red). Neural stem cells directly contact the ventricle
with their apical membrane and extend long basal processes that end on blood vessels within the ventricular wall. The neural stem cell
proliferates slowly to replicate itself (self-renewal) and to generate transit-amplifying cells. Transit-amplifying cells proliferate quickly,a n d
the progeny diﬀerentiate into immature new neurons. (c) Migration of new neurons. New neurons generated in the SVZ migrate into the
OB through the RMS, where they form elongated chain-like cell aggregates, which are surrounded by astrocytic tunnels, called glial tubes.
The new neurons (red) in the RMS secrete Slit1, whose receptor, Robo, is expressed on astrocytes (blue). Through the Slit1-Robo pathway,
the new neurons regulate the morphology of the astrocytes, promoting the formation and maintenance of the glial tubes, which are needed
forthe neurons’rapid and directional migration.(d) Diﬀerentiation of new neurons in the OB. New neurons (red) that reach the OB detach
from the chain andmigrateradially towardtheir ﬁnal destinations,where theydiﬀerentiate into two types of olfactory interneurons, granule
cells (pink) and periglomerular cells (orange) in diﬀerent layers, the GCL and GL, respectively. (e) Sagittal section of the RMS and OB
immunostained for the new neuron marker, DCX. The right panel shows a higher-magniﬁcation image of the boxed area at left. Whereas
DCX-positive new neurons migrate tangentially in chains, new neurons that migrate radially do so as individuals. Scale bars: left, 500 μm;
right, 200 μm. SVZ, subventricular zone; DG, dentate gyrus; OB, olfactory bulb; RMS, rostral migratory stream; GCL, granule cell layer;
MCL, mitral cell layer; GL, glomerular layer; DCX, doublecortin.
2.AdultNeurogenesis
In the mammalian brain, the production of new neurons
i nt h eS V Za n dt h es u b g r a n u l a rz o n e( S G Z )i nt h ed e n t a t e
gyrus(DG)ofthe hippocampuscontinuesduring adulthood
(Figure 1(a))[17–21].Here,weparticularlyfocusontheSVZ
because the new neurons generated there have the notable
ability to migrate fast and for a long distance in the adult
brain.
There are fourtypesofcellsintheadultSVZ:neuralstem
cells, transit-amplifying cells, newly generated immature
neurons, and ependymal cells (Figure 1(b))[ 22]. The neuralNeurology Research International 3
stem cells in the adult SVZ express the astrocyte-speciﬁc
protein GFAP, and their morphology is not clearly dis-
tinguishable from nonneurogenic astrocytes in other brain
regions [23, 24]. The SVZ is thought to provide a speciﬁc
microenvironment, a “stem cell niche,” that supports the
neural stem cells’ ability to maintain their self-renewing,
multipotent state. The process and regulatory mechanisms
of neurogenesis in the adult brain have been studied in
detail, particularly in rodents. In the SVZ, the stem cells
proliferate slowly and continuously to generate transit-
amplifying cells, which proliferate quickly; their progeny
become immature new neurons. New neurons in the adult
rostral migratory stream (RMS), which leads to the olfac-
tory bulb (OB) at the anterior tip of the telencephalon,
are still proliferative during their migration. Interestingly,
whereas the Wnt-β-catenin signaling is involved in the
proliferation and diﬀerentiation of transit-amplifying cells
[25], we found that Diversin, a component of the Wnt
pathway,isimportant in theproliferationofthenewneurons
[26].
It is particularly notable that the new neurons migrat-
ing through the RMS move quite quickly, 100μm/h in
rodents. This rapid, directional migration is controlled by
signals involved in cytoskeletal modiﬁcation, directional
guidance, and interactions between the new neurons and
their microenvironment [27–41].
During their migration in the RMS, the new neurons
exhibit a highly polarized morphology with an extended
leading and trailing process, and they form elongated cell
aggregates called “chains,” within which they move over and
past one another (Figure 1(c)). Polysialic acid-neural cell
adhesion molecule (PSA-NCAM) and β1-integrin expressed
on the surface of the new neurons and intracellular Cdk5
signaling areinvolvedinthischain migration [28,31,32,39].
These chains of new neurons move inside tunnels formed
by astrocytic processes, termed “glial tubes” (Figure 1(c))
[33, 35, 36], which assist the migration of the new neurons.
We recently demonstrated that the relationship between
the neurons and glia appears to be interdependent. The
tunnel-likearrangementofastrocytesdependsonadiﬀusible
protein, Slit1, secreted by the new neurons migrating inside
them.(Figure 1(c))[34]. The neuron-glia interaction may be
particularly important for neuronal migration in the adult
brain, since it includes a large glial population. In addition,
matrix metalloproteases produced by the new neurons,
and extracellular matrix molecules including tenascin-C,
proteoglycans, and the laminins are all involved in the
m i g r a t i o no fn e wn e u r o n si nt h eR M S[ 28, 33, 37].
New neurons are guided by extracellular cues to migrate
toward the OB, and we found that the directional ﬂow of
cerebrospinal ﬂuid (CSF) in the lateral ventricle plays a
critical role in their rostral migration [41]. CSF ﬂow is cre-
ated by the coordinated beating of the multiple ependymal
cell cilia, and generates concentration gradients of diﬀusible
proteins, including chemorepellents, secreted into the lateral
ventricle. The concentration gradients guide new neurons
rostrally toward theOB. In addition, new neuronsare guided
totheOBby anumber ofsecreted proteinsthatare produced
in the OB, including prokineticin 2 [38], glial cell-line-
derived neurotrophic factor (GDNF), and brain-derived
neurotrophic factor (BDNF) [29, 40].
New neurons that reach the OB detach from the chain,
and the individual cells migrate radially into the granule cell
layer and the glomerular layer, where they diﬀerentiate into
granule cells and periglomerular cells, respectively (Figures
1(d) and 1(e)). The granule cells and periglomerular cells
are GABAergic interneurons, which include a small number
of periglomerular dopaminergic interneurons. Although
the functional signiﬁcance of these new neurons remains
unclear, the neurogenic capacity of the adult rodent brain
e n c o u r a g e st h eh o p et h a tt h i sa b i l i t ym i g h tb eh a r n e s s e dt o
replace neurons destroyed by injury or disease.
The human SVZ and DG also retain some ability to
generate neurons in adulthood [21, 42], but it is diﬃcult
to evaluate human neurogenesis quantitatively, because the
experimental procedures are limited. Studies using non-
human primates and postmortem or surgically dissected
human brain tissues indicate that neurogenesis is much
less active in the human SVZ than in that of rodents [43–
45]. However, new neurons in the human SVZ exhibit a
migratory-like polarized morphology and are distributed
between the SVZ and OB. These morphological and his-
tological characteristics suggest that new neurons might
migrate for long distances in the adult human brain, but this
possibility is still controversial [45–49]. In any case, some of
the mechanisms that regulate neurogenesis are likely to be
common in humans and rodents.
3.Alterationof AdultNeurogenesisunder
Pathological Conditions
Neurogenesis in the adult brain is aﬀected by various brain
insults. Following the loss of neurons caused by pathological
conditions including stroke and neurodegenerative diseases,
newly generated neurons appear in and around the damaged
areas.
Studies of grade 3 HD patients reported that the SVZ
becomes 2.8-fold thicker, with a 2.6-fold increase in the
production of new neurons [49, 50]. Although the numbers
of transit-amplifying cells and new neurons in the patients’
SVZ had increased moderately, the most prominent increase
observed was of neural stem cells. In addition, the SVZ of
R6/2mice, a transgenic model for HD,becomesthicker,with
a marked increase in the proportion and proliferation of
neural stem cells. The self-renewal ability of neural stem cells
dissociated from the R6/2 mouse SVZ gradually increases in
parallel with disease progression. The rostral migration of
new neurons from the SVZ toward the OB is signiﬁcantly
suppressed in these mice; instead, a large population of new
neurons migrates laterally into the aﬀected striatum where
they diﬀerentiate into mature neurons (Figure 2(a))[ 16].
The precise mechanism that leads these changes remains
to be elucidated; however, the stem cells in the SVZ may
function to replace degenerated striatal neurons with new
ones, at least in the rodent HD model. In addition, the SVZ-
associated neuroregenerative response observed in HD takes
place in other pathologies, including ischemic stroke and
Parkinson’s disease (PD) [35].4 Neurology Research International
Table 1: Factors promoting the regeneration of neurons in the striatum. This table lists examples of interventions that could increase
the proliferation of neural stem/progenitor cells in the SVZ, enhance the migration of new neurons into the striatum, and promote their
diﬀerentiation/maturationand survival, which could be promisingstrategies for replacing degenerated neurons with new ones derived from
endogenous neural stem cells of the adult SVZ. SVZ, subventricular zone; RMS, rostral migratory stream; OB, olfactory bulb; TH, tyrosine
hydroxylase;EGF, epidermalgrowthfactor;FGF-2, ﬁbroblastgrowthfactor2;TGF-α,transforminggrowthfactor α;GDNF, glialcell-derived
neurotrophic factor; SDF-1α, stromal cell-derived factor 1α; BDNF, brain-derived neurotrophic factor; aCSF artiﬁcial cerebrospinal ﬂuid;
HI, hypoxic-ischemic cerebral injury; MCAO, middle cerebral artery occlusion; 6-OHDA, 6-hydrodopamine; MPTP, 1-methyl-4-phenyl-
1,2,3,6-tetrahydroxydropyridine; hNSCs, human neural stem cells; ESCs, embryonic stem cells.
Protein Model Technique Function in neurogenesis References
EGF
Intact Infusion into the lateral ventricle using an
osmotic pump
Proliferation of SVZ progenitors (18-fold
increase compared with saline infusion
group)
[69]
Intact Infusion into the lateral ventricle using an
osmotic pump
Proliferation of SVZ progenitors (9.5-fold
increase compared with aCSF infusion
group)
[70]
MCAO Overexpression in the SVZ
Proliferation of SVZ progenitors (1.7-fold
increase compared with control vector
treatment group)
[64]
FGF-2
Intact Infusion into the lateral ventricle using an
osmotic pump
Proliferation of SVZ progenitors (2.4-fold
increase compared with serum albumin
infusion group)
[69]
Intact Infusion into the lateral ventricle using an
osmotic pump
Proliferation of SVZ progenitors (3.3-fold
increase compared with aCSF infusion
group)
[70]
MCAO Infusion into the cisterna magna Proliferation of SVZ progenitors (increase
compared with vehicle treatment group) [65]
Angiopoietin 2 6-OHDA Infusion into the lateral ventricle Proliferation of SVZ progenitors (increase
compared with BSA treatment group) [71]
TGF-α
Intact Infusion into the lateral ventricle using an
osmotic pump
Proliferation of SVZ progenitors (14-fold
increase compared with albmin infusion
group)
[69]
6-OHDA Infusion into the striatum using an
osmotic pump
Proliferation of SVZ progenitors (increase
compared with PBS infusion group) [72]
6-OHDA Infusion into the striatum using an
osmotic pump
Generation of neurons in the striatum
(immature neuron, increase compared with
aCSF infusion group)
[73]
GDNF MCAO Infusion into the striatum using an
osmotic pump
Generation of neurons in the striatum
( i m m a t u r en e u r o n ,1 . 8 6 - f o l d ;m a t u r e
neuron, 1.2-fold, increase compared with
PBS treatment group)
[66]
SDF-1α HI
Migration of implanted hNSCs toward the
injured area in ischemic brain slice
(increase)
[57]
Tenascin-R Intact Tenascin-R expressing cell implantation
into the striatum
Migration of SVZ new neurons toward the
striatum (4-fold increase compared with the
Tenascin nonexpression cell implanted
group)
[74]
Quinolic
acid
TNR-expressing ESCs implantation into
the striatum
Migration of SVZ new neurons into the
striatum (increase compared with
TNR-nonexpression ESCs implanted group)
[75]
BDNF
Intact Infusion into the lateral ventricle using an
osmotic pump
Generation of neurons in the OB (increase
compared with PBS infusion group) [76]
Intact Infusion into the lateral ventricle using an
osmotic pump
Generation of neurons in the striatum
(increase compared with PBS infusion
group)
[77]
R6/2 Overexpression in the SVZ
Generation of neurons in the striatum
(21-fold increase compared with saline
group)
[68]Neurology Research International 5
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Figure 2: Neurogenesis after neuron loss. (a) Spontaneous neuronal regeneration in HD. In parallel with the progressive degeneration of
striatalneuronscausedbyHD,theproductionofnewneuronsintheSVZincreasessigniﬁcantly.Thesenewneuronsmigrateintotheaﬀected
striatum, where only some diﬀerentiate into mature neurons. (b) Migration of new neurons toward the damaged area in the mouse MCAO
model. MCAO causes an infarction in the striatum and adjacent parietal cortex. Within a week of the insult, neural stem cells (blue) and
transit-amplifyingcells(green)intheSVZbegin toproliferate,andby twoorthree weeksafterMCAO,newneurons(red)migrateandappear
at the border of the damaged area in the striatum. (c) At left, a schematic drawing of the coronalbrain section 18 days after MCAO. At right
a section immunostained for DCX. Boxed area is shown at higher magniﬁcation at far right. Many new neurons migrate into the ipsilateral
striatum,but notthe contralateralstriatum.Somenew neurons migrateinto the striatum in chain-likeclusters (farright,arrowheads).Scale
bars: left, 500 μm; right, 200μm. (d) Schematic drawing of new neurons migrating along blood vessels toward the damaged striatum. (e)
Confocal projection image of new neurons migrating along blood vessels, in a coronal brain section, 18 days after MCAO. The section was
immunostainedforDCX (green)andanendothelialcell marker,PECAM-1(red). Scalebar:50μm.MCAO,middle cerebral artery occlusion;
SVZ, subventricular zone; OB, olfactory bulb; DCX, doublecortin; PECAM-1, platelet endothelial cell adhesion molecule-1.
Cerebral ischemia is the most commonly studied model
of neuronal regeneration after extensive neuronal death
(Figure 2(b)). In patients after ischemic stroke, cell prolif-
eration and the production of new neurons in the SVZ are
increased, and immature new neurons appear in the cortex
close to injured areas and in the striatum close to the SVZ
[51–53]. The mechanism and functional signiﬁcance of the
ischemia-induced neurogenesis have mostly been studied
using rodent models of transient middle cerebral artery
occlusion (MCAO), an experimental model of focal brain
ischemia that causes infarction of the ipsilateral striatum and
adjacent neocortex [54]. The new neurons generated in the
SVZ have a migratory morphology that is directed toward
the infarct area, and frequently form chain-like aggregates
similar to those observed in the RMS (Figure 2(c)). Our
lineage-speciﬁc tracing study revealed that the SVZ is almost6 Neurology Research International
the sole source of migrating new neurons in the striatum
[55]. We also found that new neurons in the striatum
are closely associated with astrocytic processes and migrate
along blood vessels (Figures 2(d) and 2(e))[ 55, 56]. Several
proteins produced by the glia and endothelial cells around
the infarct area are implicated in this migration, as are their
receptors and the MMPs expressed by the new neurons [57–
60]. After the migration, most of the new neurons die before
theymature,butsomesurvivetodiﬀerentiateintofunctional
neurons with synaptic contacts.
In a rat MCAO model, the number of new striatal neu-
rons increased 31-fold compared with that in sham-operated
animals [54]. Using the immunocytochemical detection of
BrdU, a thymidine analog that is incorporated into DNA
during cell proliferation, and of NeuN, a neuronal marker,
newly generated neurons have been identiﬁed in the injured
striatum of several MCAO models. When BrdU (50mg/kg)
was administered twice a day for 14 days to post-MCAO
rats,thedensityofBrdU/NeuN-colabelednewneuronsinthe
striatum 6 weeks after MCAO was more than 700cells/mm3.
On the other hand, in a nonhuman primate (common
marmoset) MCAO stroke model, BrdU (50mg/kg) injec-
tions once a day for 18 days after MCAO resulted in a
density of BrdU/NeuN-colabeled new striatal neurons 45
days after MCAO that was less than 3cells/mm2,t h a ti s ,
about 50cells/mm3, considering the thickness of the brain
sections [61]. These reports suggest that the eﬃciency of
neuronalregenerationislowerintheprimatebrain,although
a precise comparison is not possible due to the diﬀerence
in BrdU-treatment procedures. Moreover, even in the rat
MCAO model, these new neurons could replace only about
0.2% of the dead striatal neurons [54], suggesting that the
spontaneous neuronal regeneration would be insuﬃcient to
replace the functions of the lost neurons in human patients.
Because of the low eﬃciency of neuronal regeneration,
interventions that promote this process are now the focus
of intense study. Growth factors that promote cell prolifer-
ation, diﬀerentiation, migration, and/or survival have been
reported to act on neural stem cells and/or their progenies to
enhance neuronal regeneration [62, 63]( Table 1). In MCAO
model animals, epidermal growth factor (EGF) overexpres-
sion in the SVZ and the intracisternal administration of
ﬁbroblast growth factor 2 (FGF-2) induced increases in the
number of proliferating cells in the SVZ [64, 65]w h e r e a s
infusion of GDNF around the infarct area increased the new
neurons in the region by 2-fold [66]. On the other hand,
the stromal cell-derived factor-1α (SDF-1α)C X C R 4s i g n a l
has been reported to be involved in neuronal migration
toward the infarct area [57, 59, 67]. Furthermore, in the
R6/2modelmice,BDNFoverexpressionintheSVZincreased
the production of new striatal neurons by about 21-fold,
which was enhanced by the co-overexpression of Noggin, a
soluble inhibitor of the bone morphogenic proteins (BMPs)
[68]. Some of these growth factors may thus be eﬀective in
reducing the pathology associated with neuronal loss.
Alterations in neurogenesis are also observed in PD, a
more common neurodegenerative disease than HD. PD is a
motor system disorder characterized by the selective degen-
eration of dopaminergic neurons in the substantia nigra pars
compacta, a basal ganglion of the midbrain, that project
into the striatum. Therefore, treatments that increase the
dopaminergic stimulation of the striatum improve neuro-
logical symptoms. In animal models of PD, after chemically
induced dopaminergic denervation of the striatum, new
neurons migrate from the SVZ to the striatum, where they
diﬀerentiate into dopaminergic neurons [78–80]. However,
these reports are controversial because other researchers
showed that the new neurons did not eﬃciently migrate into
the denervated striatum, but into the OB, and that the SVZ-
derived migrating progenitors that did arrive in the striatum
never diﬀerentiated into mature dopaminergic neurons [81].
Therefore, eveniftheSVZcangeneratenew neuronsthat
migrate to the striatum in pathological conditions, such as
HD, these neurons may not replace the functionality of the
lost neurons, possibly because theydonot mature and diﬀer-
entiate into the needed neuronal types. As mentioned above,
new neurons generated in the SVZ become interneurons
in the OB. In contrast, more than 90% of striatal neurons
are medium-sized spiny projection neurons, and these are
the neurons that are mainly injured in HD and cerebral
ischemia [82–87]. Although some previous studies reported
the regeneration of mature neurons with phenotypes of
striatal projection neurons [54, 88], more recent studies
demonstrated that, after ischemic stroke, the new neurons
that were generated in the SVZ and diﬀerentiated in the
striatum almost exclusively became calretinin-expressing
neurons, a major type of olfactory interneuron [89–91].
These ﬁndings suggested that the neurons generated in the
SVZ have a limited diﬀerentiative capacity for neuronal
regeneration. In considering how to attenuate the progres-
sion of HD, it is particularly important to learn whether and
how we can control the fatesof new neuronsgenerated in the
adult brain so that they adopt striatal neuronal phenotypes.
Further studies are needed to address these points.
4.Conclusion
The spontaneous regeneration response of the adult SVZ
to pathological neuronal loss does not lead to the regen-
eration of the lost neurons, because of limitations in the
numbers of neurons generated and the fates they adopt.
However, many studies support the idea that interventions
to increase the production of new neurons in the SVZ and
promote their migration, maturation, and survival in the
damaged area could be beneﬁcial for treating a variety of
neurological deﬁcits, including HD (Table 1). To develop
a new therapeutic strategy for pathological neuronal loss,
including in cases of HD and stroke, using this system, it
will be critical to develop a more precise and comprehensive
understanding of the mechanisms that regulate neurogenesis
in both physiological and pathological conditions.
Acknowledgments
The authorsapologizetoallthosewhose work theycouldnot
citebecauseofspacelimitations. The authorsthank allofour
collaborators for their contributions to the original research
andmembersoftheSawamoto laboratoriesfortheirvaluableNeurology Research International 7
discussions. This paper was supported by research grants
from the Ministry of Education, Culture, Sports, Science,
and Technology (MEXT), the Ministry of Health, Labor,
and Welfare (MHLW), the Japan Society for the Promotion
of Science (JSPS), the Human Frontier Science Program
(HFSP), and the Funding Program for Next Generation
World-Leading Researchers.
References
[1] G. P. Bates,“The molecular genetics ofHuntington disease—a
history,” Nature Reviews Genetics, vol. 6, no. 10, pp. 766–773,
2005.
[ 2 ]A .M o n t o y a ,B .H .P r i c e ,M .M e n e a r ,a n dM .L e p a g e ,“ B r a i n
imaging and cognitive dysfunctions in Huntington’s disease,”
Journal of Psychiatry and Neuroscience, vol. 31, no. 1, pp. 21–
29, 2006.
[ 3 ] J .P .V o n s a t t e l ,R .H .M y e r s ,a n dT .J .S t e v e n s ,“ N e u -
ropathological classiﬁcation of Huntington’s disease,” Journal
of Neuropathology and Experimental Neurology, vol. 44, no. 6,
pp. 559–577, 1985.
[4] J. F. Gusella, N. S. Wexler, P. M. Conneally et al., “A
polymorphic DNA marker genetically linked to Huntington’s
disease,” Nature, vol. 306, no. 5940, pp. 234–238, 1983.
[5] M.E.MacDonald,C.M.A mbr ose,M.P .Du y aoetal.,“ Anov el
gene containing a trinucleotide repeat that is expanded and
unstable on Huntington’s disease chromosomes,”Cell, vol. 72,
no. 6, pp. 971–983, 1993.
[6] R. G. Snell, J. C. MacMillan, J. P. Cheadle et al., “Relationship
between trinucleotide repeat expansion and phenotypic vari-
ation in Huntington’s disease,” Nature Genetics,v o l .4 ,n o .4 ,
pp. 393–397, 1993.
[ 7 ]M .D i F i g l i a ,E .S a p p ,K .O .C h a s ee ta l . ,“ A g g r e g a t i o no fh u n t -
ingtininneuronalintranuclearinclusionsanddystrophicneu-
ritesinbrain,”Science,vol.277,no.5334,pp.1990–1993,1997.
[8] R. J. Ferrante, N. W. Kowall, and M. F. Beal, “Selective sparing
of a class of striatal neurons in Huntington’s disease,” Science,
vol. 230, no. 4725, pp. 561–563, 1985.
[ 9 ]P .O .B a u e r ,A .G o s w a m i ,H .K .W o n ge ta l . ,“ H a r n e s s i n g
chaperone-mediated autophagy for the selective degradation
of mutant huntingtin protein,” Nature Biotechnology, vol. 28,
no. 3, pp. 256–263, 2010.
[10] J. M. Gil and A. C. Rego, “The R6 lines of transgenic mice: a
model for screening new therapies for Huntington’s disease,”
Brain Research Reviews, vol. 59, no. 2, pp. 410–431, 2009.
[ 1 1 ]X .G u ,E .R .G r e i n e r ,R .M i s h r ae ta l . ,“ S e r i n e s1 3a n d1 6a r e
critical determinants of full-length human mutant huntingtin
induced disease pathogenesis in HD mice,” Neuron,v o l .6 4 ,
no. 6, pp. 828–840, 2009.
[12] J. P. Miller, J. Holcomb, I. Al-Ramahi et al., “Matrix metallo-
proteinases are modiﬁers of huntingtin proteolysis and
toxicity in Huntington’s disease,” Neuron,v o l .6 7 ,n o .2 ,p p .
199–212, 2010.
[13] Y. Enokido, T. Tamura, H. Ito et al., “Mutant huntingtin
impairs Ku70-mediated DNA repair,” J o u r n a lo fC e l lB i o l o g y ,
vol. 189, no. 3, pp. 425–443, 2010.
[ 1 4 ]M .A .C u r t i s ,E .B .P e n n e y ,A .G .P e a r s o ne ta l . ,“ I n c r e a s e d
cell proliferation and neurogenesis in the adult human
Huntington’s disease brain,” Proceedings of the National
Academy of Sciences of the United States of America, vol. 100,
no. 15, pp. 9023–9027, 2003.
[ 1 5 ]M .A .C u r t i s ,H .J .W a l d v o g e l ,B .S y n e k ,a n dR .L .M .F a u l l ,
“A histochemical and immunohistochemical analysis of the
subependymal layer in the normal and Huntington’s disease
brain,” Journal of Chemical Neuroanatomy,v o l .3 0 ,n o .1 ,p p .
55–66, 2005.
[16] C. M. C. Batista, T. E. Kippin, S. Willaime-Morawek, M. K.
Shimabukuro, W. Akamatsu, and D. van der Kooy, “A pro-
gressive and cell non-autonomous increase in striatal neural
stem cells in the Huntington’s disease R6/2 mouse,” Journal of
Neuroscience, vol. 26, no. 41, pp. 10452–10460, 2006.
[17] J. Altman, “Autoradiographic and histological studies of
postnatal neurogenesis. IV. Cell proliferation and migration
in the anterior forebrain, with special reference to persisting
neurogenesis in the olfactory bulb,” Journal of Comparative
Neurology, vol. 137, no. 4, pp. 433–457, 1969.
[18] M. S. Kaplan and J. W. Hinds, “Neurogenesis in the adult
rat: electron microscopic analysis of light radioautographs,”
Science, vol. 197, no. 4308, pp. 1092–1094, 1977.
[19] H. A. Cameron, C. S. Woolley, B. S. McEwen, and E. Gould,
“Diﬀerentiation of newly born neurons and glia in the dentate
gyrus of the adult rat,” Neuroscience,v o l .5 6 ,n o .2 ,p p .
337–344, 1993.
[20] F. Doetsch and A. Alvarez-Buylla, “Network of tangential
pathways for neuronal migration in adult mammalian brain,”
Proceedings of the National Academy of Sciences of the United
States of America, vol. 93, no. 25, pp. 14895–14900, 1996.
[21] P. S. Eriksson, E. Perﬁlieva, T. Bj¨ ork-Eriksson et al., “Neuro-
genesis in the adult human hippocampus,” Nature Medicine,
vol. 4, no. 11, pp. 1313–1317, 1998.
[22] A. Alvarez-Buylla and J. M. Garc´ ıa-Verdugo, “Neurogenesis
in adult subventricular zone,” Journal of Neuroscience, vol. 22,
no. 3, pp. 629–634, 2002.
[ 2 3 ]F .D o e t s c h ,I .C a i l l e ,D .A .L i m ,J .M .G a r c i a - V e r d u g o ,a n d
A. Alvarez-Buylla, “Subventricular zone astrocytes are neural
stem cells in the adult mammalian brain,” Cell, vol. 97, no. 6,
pp. 703–716, 1999.
[ 2 4 ]A .D .R .G a r c i a ,N .B .D o a n ,T .I m u r a ,T .G .B u s h ,a n dM .V .
Sofroniew, “GFAP-expressing progenitors are the principal
source of constitutive neurogenesis in adult mouse forebrain,”
Nature Neuroscience, vol. 7, no. 11, pp. 1233–1241, 2004.
[25] K. Adachi, Z. Mirzadeh, M. Sakaguchi et al., “β-catenin
signaling promotes proliferation of progenitor cells in the
adult mouse subventricular zone,” Stem Cells, vol. 25, no. 11,
pp. 2827–2836, 2007.
[26] M. Ikeda, Y. Hirota, M. Sakaguchi et al., “Expression and
proliferation-promoting role of diversin in the neuronally
committed precursor cells migrating in the adult mouse
brain,” Stem Cells, vol. 28, no. 11, pp. 2017–2026, 2010.
[27] R. Belvindrah, S. Hankel, J. Walker, B. L. Patton, and U.
M¨ uller, “β1 integrins control the formation of cell chains in
the adult rostral migratory stream,” Journal of Neuroscience,
vol. 27, no. 10, pp. 2704–2717, 2007.
[ 2 8 ]S .B o v e t t i ,P .B o v o l i n ,I .P e r r o t e a u ,a n dA .C .P u c h e ,“ S u b -
ventricular zone-derived neuroblastmigrationto theolfactory
bulb is modulated by matrix remodelling,” European Journal
of Neuroscience, vol. 25, no. 7, pp. 2021–2033, 2007.
[29] S. Chiaramello, G. Dalmasso, L. Bezin et al., “BDNF/TrkB
interaction regulates migration of SVZ precursor cells via
PI3-K and MAP-K signalling pathways,” European Journal of
Neuroscience, vol. 26, no. 7, pp. 1780–1790, 2007.
[30] H. T. Ghashghaei, J. Weber, L. Pevny et al., “The role of
neuregulin-ErbB4 interactions on the proliferation and org-
anization of cells in the subventricular zone,” Proceedings8 Neurology Research International
of the National Academy of Sciences of the United States of
America, vol. 103, no. 6, pp. 1930–1935, 2006.
[31] Y. Hirota, T. Ohshima, N. Kaneko et al., “Cyclin-dependent
kinase 5 is required for control of neuroblast migration in the
postnatal subventricular zone,” Journal of Neuroscience,v o l .
27, no. 47, pp. 12829–12838, 2007.
[32] H. Hu, H. Tomasiewicz, T. Magnuson, and U. Rutishauser,
“The role of polysialic acid in migration of olfactory bulb
interneuron precursors in the subventricular zone,” Neuron,
vol. 16, no. 4, pp. 735–743, 1996.
[33] A. Jankovski and C. Sotelo, “Subventricular zone-olfactory
bulb migratory pathway in the adult mouse: cellular
composition and speciﬁcity as determined by heterochronic
and heterotopic transplantation,” Journal of Comparative
Neurology, vol. 371, no. 3, pp. 376–396, 1996.
[34] N. Kaneko, O. Mar´ ı n ,M .K o i k ee ta l . ,“ N e wn e u r o n sc l e a rt h e
path of astrocytic processes for their rapid migration in the
adult brain,” Neuron, vol. 67, no. 2, pp. 213–223, 2010.
[35] N. Kaneko and K. Sawamoto, “Adult neurogenesis and its
alteration under pathological conditions,” Neuroscience Re-
search, vol. 63, no. 3, pp. 155–164, 2009.
[ 3 6 ]C .L o i s ,J .M .G a r c ´ ıa-Verdugo, and A. Alvarez-Buylla, “Chain
migration of neuronal precursors,” Science, vol. 271, no. 5251,
pp. 978–981, 1996.
[37] S. I. Murase and A. F. Horwitz, “Deleted in colorectal
carcinoma and diﬀerentially expressed integrins mediate
the directional migration of neural precursors in the rostral
migratory stream,” Journal of Neuroscience,v o l .2 2 ,n o .9 ,p p .
3568–3579, 2002.
[ 3 8 ]K .L .N g ,J .D .L i ,M .Y .C h e n g ,F .M .L e s l i e ,A .C .L e e ,a n d
Q. Y. Zhou, “Neuroscience: dependence of olfactory bulb
neurogenesis on prokineticin 2 signaling,” Science, vol. 308,
no. 5730, pp. 1923–1927, 2005.
[39] K. Ono, H. Tomasiewicz, T. Magnuson, and U. Rutishauser,
“N-CAM mutation inhibits tangential neuronal migration
and is phenocopied by enzymatic removal of polysialic acid,”
Neuron, vol. 13, no. 3, pp. 595–609, 1994.
[ 4 0 ] G .P a r a t c h a ,C .F .I b ´ a˜ nez, and F. Ledda, “GDNF is a
chemoattractant factor for neuronal precursor cells in
the rostral migratory stream,” Molecular and Cellular
Neuroscience, vol. 31, no. 3, pp. 505–514, 2006.
[41] K. Sawamoto, H. Wichterle, O. Gonzalez-Perez et al., “New
neurons follow the ﬂow of cerebrospinal ﬂuid in the adult
brain,” Science, vol. 311, no. 5761, pp. 629–632, 2006.
[42] P. J. Bernier, J. Vinet, M. Cossette, and A. Parent, “Characteri-
zation of the subventricular zone of the adult human brain:
evidence for the involvement of Bcl-2,” Neuroscience Research,
vol. 37, no. 1, pp. 67–78, 2000.
[43] D. R. Kornack and P. Rakic, “The generation, migration,
and diﬀerentiation of olfactory neurons in the adult primate
brain,” Proceedings of the National Academy of Sciences of the
United States of America, vol. 98, no. 8, pp. 4752–4757, 2001.
[44] K. Sawamoto, Y. Hirota, C. Alfaro-Cervello et al., “Cellular
composition and organization of the subventricular zone and
rostral migratory stream in the adult and neonatal common
marmoset brain,” Journal of Comparative Neurology, vol. 519,
no. 4, pp. 690–713, 2011.
[45] H. Sanai, A. D. Tramontin, A. Qui˜ nones-Hinojosa et al.,
“Unique astrocyte ribbon in adult human brain contains
neural stem cells but lacks chain migration,” Nature, vol. 427,
no. 6976, pp. 740–744, 2004.
[46] A. B´ edard and A. Parent, “Evidence of newly generated neu-
rons in the human olfactory bulb,” Developmental Brain Re-
search, vol. 151, no. 1-2, pp. 159–168, 2004.
[47] M. A. Curtis, M. Kam, U. Nannmark et al., “Human neu-
roblasts migrate to the olfactory bulb via a lateral ventricular
extension,” Science, vol. 315, no. 5816, pp. 1243–1249,
2007.
[48] N. Sanai, M. S. Berger, J. M. Garcia-Verdugo, and A. Alvarez-
Buylla, “Comment on “human neuroblasts migrate to the
olfactory bulb via a lateralventricular extension”,” Science,v ol.
318, no. 5849, p. 393b, 2007.
[49] A. Qui˜ nones-Hinojosa, N. Sanai, M. Soriano-Navarro et
al., “Cellular composition and cytoarchitecture of the adult
human subventricular zone: a niche of neural stem cells,”
Journal ofComparative Neurology, vol.494,no.3,pp.415–434,
2006.
[50] M. A. Curtis, E. B. Penney, J. Pearson, M. Dragunow, B.
Connor, and R. L. M. Faull, “The distribution of progenitor
cells in the subependymal layer of the lateral ventricle in the
normaland Huntington’s disease humanbrain,” Neuroscience,
vol. 132, no. 3, pp. 777–788, 2005.
[51] K. Jin, X. Wang, L. Xie et al., “Evidence for stroke-induced
neurogenesis in the human brain,” Proceedings of the National
Academy of Sciences of the United States of America, vol. 103,
no. 35, pp. 13198–13202, 2006.
[ 5 2 ]J .M a c a s ,C .N e r n ,K .H .P l a t e ,a n dS .M o m m a ,“ I n c r e a s e d
generation of neuronal progenitors after ischemic injury in
the aged adult human forebrain,” Journal of Neuroscience,v o l .
26, no. 50, pp. 13114–13119, 2006.
[53] J. Mart´ ı-F` abregas, M. Romaguera-Ros, U. G´ omez-Pinedo
et al., “Proliferation in the human ipsilateral subventricular
zone after ischemic stroke,” Neurology, vol. 74, no. 5, pp.
357–365, 2010.
[54] A. Arvidsson, T. Collin, D. Kirik, Z. Kokaia, and O. Lindvall,
“Neuronal replacement from endogenous precursors in the
adult brain after stroke,” Nature Medicine,v o l .8 ,n o .9 ,p p .
963–970, 2002.
[55] T.Yamashita,M.Ninomiya,P.H.Acostaetal.,“Subventricular
zone-derived neuroblasts migrate and diﬀerentiate into
mature neurons in the post-stroke adult striatum,” Journal of
Neuroscience, vol. 26, no. 24, pp. 6627–6636, 2006.
[56] T. Kojima, Y. Hirota, M. Ema et al., “Subventricular zone-
derived neural progenitor cells migrate along a blood vessel
scaﬀold toward the post-stroke striatum,” Stem Cells, vol. 28,
no. 3, pp. 545–554, 2010.
[ 5 7 ]J .I m i t o l a ,K .R a d d a s s i ,K .I .P a r ke ta l . ,“ D i r e c t e dm i g r a t i o n
of neural stem cells to sites of CNS injury by the stromal
cell-derived factor 1α/CXC chemokine receptor 4 pathway,”
Proceedings of the National Academy of Sciences of the
United States of America, vol. 101, no. 52, pp. 18117–18122,
2004.
[ 5 8 ]J .J .O h a b ,S .F l e m i n g ,A .B l e s c h ,a n dS .T .C a r m i c h a e l ,“ A
neurovascular niche for neurogenesis after stroke,” Journal of
Neuroscience, vol. 26, no. 50, pp. 13007–13016, 2006.
[59] P. Thored, A. Arvidsson,E. Cacciet al.,“Persistent production
of neurons from adult brain stem cells during recovery after
stroke,” Stem Cells, vol. 24, no. 3, pp. 739–747, 2006.
[ 6 0 ]Y .P .Y a n ,K .A .S a i l o r ,B .T .L a n g ,S .W .P a r k ,R .V e m u g a n t i ,
and R. J. Dempsey, “Monocyte chemoattractant protein-1
plays a critical role in neuroblast migrationafter focal cerebral
ischemia,” Journal of Cerebral Blood Flow and Metabolism,v o l .
27, no. 6, pp. 1213–1224, 2007.Neurology Research International 9
[61] E. Bihel, P. Pro-Sistiaga, A. Letourneur et al., “Permanent or
transient chronic ischemic stroke in the non-human primate:
behavioral, neuroimaging, histological, and immunohisto-
chemical investigations,” Journal of Cerebral Blood Flow and
Metabolism, vol. 30, no. 2, pp. 273–285, 2010.
[62] T. C. Burns, C. M. Verfaillie, and W. C. Low, “Stem cells
for ischemic brain injury: a critical review,” Journal of
Comparative Neurology, vol. 515, no. 1, pp. 125–144, 2009.
[63] R.L.Zhang,Z.G.Zhang,andM.Chopp,“Ischemicstrokeand
neurogenesis in the subventricular zone,” Neuropharmacology,
vol. 55, no. 3, pp. 345–352, 2008.
[64] S. Sugiura, K. Kitagawa, S. Tanaka et al., “Adenovirus-
mediated gene transfer of heparin-binding epidermal
growth factor-like growth factor enhances neurogenesis and
angiogenesis after focal cerebral ischemia in rats,” Stroke,v o l .
36, no. 4, pp. 859–864, 2005.
[65] K. Wada,H. Sugimori,P. G. Bhide,M. A. Moskowitz,and S.P.
Finklestein, “Eﬀect of basic ﬁbroblast growth factor treatment
on brain progenitor cells after permanent focal ischemia in
rats,” Stroke, vol. 34, no. 11, pp. 2722–2728, 2003.
[66] T. Kobayashi, H. Ahlenius,P. Thored, R. Kobayashi, Z. Kokaia,
and O. Lindvall, “Intracerebral infusion of glial cell line-
derived neurotrophic factor promotes striatal neurogenesis
after strokein adult rats,”Stroke, vol. 37,no. 9,pp. 2361–2367,
2006.
[67] A. M. Robin, Z. G. Zhang, L. Wang et al., “Stromal cell-
derived factor 1α mediates neural progenitor cell motility
after focal cerebral ischemia,” Journal of Cerebral Blood Flow
and Metabolism, vol. 26, no. 1, pp. 125–134, 2006.
[68] S. R. Cho, A. Benraiss, E. Chmielnicki, A. Samdani, A.
Economides, and S. A. Goldman, “Induction of neostriatal
neurogenesis slowsdisease progression in a transgenic murine
modelofHuntingtondisease,”Journal of Clinical Investigation,
vol. 117, no. 10, pp. 2889–2902, 2007.
[ 6 9 ]C .G .C r a i g ,V .T r o p e p e ,C .M .M o r s h e a d ,B .A .R e y n o l d s ,
S. Weiss, and D. van der Kooy, “In vivo growth factor
expansion of endogenous subependymal neural precursor cell
populationsintheadultmousebrain,”JournalofNeuroscience,
vol. 16, no. 8, pp. 2649–2658, 1996.
[70] H. G. Kuhn, J. Winkler, G. Kempermann, L. J. Thal, and F.
H. Gage, “Epidermal growth factor and ﬁbroblast growth
factor-2 have diﬀerent eﬀects on neural progenitors in the
adult rat brain,” Journal of Neuroscience, vol. 17, no. 15, pp.
5820–5829, 1997.
[71] A. Androutsellis-Theotokis, M. A. Rueger, D. M. Park et al.,
“Targeting neuralprecursors intheadult brainrescues injured
dopamine neurons,” Proceedings of the National Academy of
Sciences of the United States of America, vol. 106, no. 32, pp.
13570–13575, 2009.
[ 7 2 ]A .d eC h e v i g n y ,O .C o o p e r ,A .V i n u e l ae ta l . ,“ F a t em a p p i n g
and lineage analyses demonstrate the production of a large
number of striatal neuroblasts after transforming growth fac-
torαandnogginstriatalinfusionsintothedopamine-depleted
striatum,” Stem Cells, vol. 26, no. 9, pp. 2349–2360, 2008.
[73] J. Fallon, S. Reid, R. Kinyamu et al., “In vivo induction of
massive proliferation, directed migration, and diﬀerentiation
of neural cells in the adult mammalian brain,” Proceedings
of the National Academy of Sciences of the United States of
America, vol. 97, no. 26, pp. 14686–14691, 2000.
[74] A. Saghatelyan, A. de Chevigny, M. Schachner, and P. M.
Lledo, “Tenascin-R mediates activity-dependent recruitment
of neuroblasts in the adult mouse forebrain,” Nature
Neuroscience, vol. 7, no. 4, pp. 347–356, 2004.
[75] G. Hargus, Y. Cui, J. S. Schmid et al., “Tenascin-R promotes
neuronal diﬀerentiation of embryonic stem cells and
recruitment of host-derived neural precursor cells after
excitotoxic lesion of the mouse striatum,” Stem Cells, vol. 26,
no. 8, pp. 1973–1984, 2008.
[76] T. Zigova, V. Pencea, S. J. Wiegand, and M. B. Luskin,
“Intraventricular administration of BDNF increases the
number of newly generated neurons in the adult olfactory
bulb,” Molecular and Cellular Neurosciences,v o l .1 1 ,n o .4 ,p p .
234–245, 1998.
[ 7 7 ]V .P e n c e a ,K .D .B i n g a m a n ,S .J .W i e g a n d ,a n dM .B .L u s k i n ,
“Infusion of brain-derived neurotrophic factor into the
lateral ventricle of the adult rat leads to new neurons in
the parenchyma of the striatum, septum, thalamus, and
hypothalamus,” Journal of Neuroscience, vol. 21, no. 17, pp.
6706–6717, 2001.
[78] E. Huisman, H. B. M. Uylings, and P. V. Hoogland, “A
100% increase of dopaminergic cells in the olfactory bulb
may explain hyposmia in parkinson’s disease,” Movement
Disorders, vol. 19, no. 6, pp. 687–692, 2004.
[79] B. Winner, M. Geyer, S. Couillard-Despres et al., “Striatal
deaﬀerentation increases dopaminergic neurogenesis in the
adult olfactory bulb,” Experimental Neurology, vol. 197, no. 1,
pp. 113–121, 2006.
[ 8 0 ] M .Z h a o ,S .M o m m a ,K .D e l f a n ie ta l . ,“ E v i d e n c ef o r
neurogenesis in the adult mammalian substantia nigra,”
Proceedings of the National Academy of Sciences of the United
States of America, vol. 100, no. 13, pp. 7925–7930, 2003.
[81] O. Cooper and O. Isacson, “Intrastriatal transforming growth
factorαdeliverytoamodelofParkinson’sdiseaseinducespro-
liferation and migration of endogenous adult neural progen-
itor cells without diﬀerentiation into dopaminergic neurons,”
Journal of Neuroscience, vol. 24, no. 41, pp. 8924–8931, 2004.
[82] C.A.Meade,Y.P.Deng,F.R.Fuscoetal.,“Cellularlocalization
and development of neuronal intranuclear inclusions in
striatal and cortical neurons in R6/2 transgenic mice,” Journal
of Comparative Neurology, vol. 449, no. 3, pp. 241–269, 2002.
[83] R. L. Albin, A. Reiner, K. D. Anderson, J. B. Penney, and A.
B. Young, “Striatal and nigral neuron subpopulations in rigid
Huntington’s disease: implications for the functional anatomy
of chorea and rigidity-akinesia,” Annals of Neurology, vol. 27,
no. 4, pp. 357–365, 1990.
[84] R. L. Albin, A. B. Young, J. B. Penney et al., “Abnormalities of
striatal projection neurons and N-methyl-D-aspartate recep-
tors in presymptomatic Huntington’s disease,” The New Eng-
land JournalofMedicine,vol.322,no.18,pp.1293–1298,1990.
[85] R. L. Albin, A. Reiner, K. D. Anderson et al., “Preferential
loss of striato-external pallidal projection neurons in
presymptomatic Huntington’s disease,” Annals of Neurology,
vol. 31, no. 4, pp. 425–430, 1992.
[ 8 6 ]H .K i y a m a ,A .S e t o - O h s h i m a ,a n dP .C .E m s o n ,“ C a l b i n d i n
D(28K) as a marker for the degeneration of the striatonigral
pathway in Huntington’s disease,” Brain Research,vol. 525,no.
2, pp. 209–214, 1990.
[ 8 7 ]E .K .R i c h ﬁ e l d ,K .A .M a g u i r e - Z e i s s ,H .E .V o n k e m a n ,a n d
P. Voorn, “Preferential loss of preproenkephalin versus
preprotachykinin neurons from the striatum of Huntington’s
disease patients,” Annals of Neurology,v o l .3 8 ,n o .6 ,p p .
852–861, 1995.
[ 8 8 ]J .M .P a r e n t ,Z .S .V e x l e r ,C .G o n g ,N .D e r u g i n ,a n dD .M .
Ferriero, “Rat forebrain neurogenesis and striatal neuron
replacement after focal stroke,” Annals of Neurology, vol. 52,
no. 6, pp. 802–813, 2002.10 Neurology Research International
[89] F. Liu, Y. You, X. Li et al., “Brain injury does not alter
the intrinsic diﬀerentiation potential of adult neuroblasts,”
Journal of Neuroscience, vol. 29, no. 16, pp. 5075–5087, 2009.
[90] E. Gustafsson, G. Andsberg, V. Darsalia et al., “Anterograde
delivery of brain-derived neurotrophic factor to striatum via
nigral transduction of recombinant adeno-associated virus
increases neuronal death but promotes neurogenic response
following stroke,” European Journal of Neuroscience,v o l .1 7 ,
no. 12, pp. 2667–2678, 2003.
[91] T .T e ramot o ,J .Qiu ,J .C .Plu mie r ,andM.A .M osk o wit z,“ E G F
ampliﬁes the replacement of parvalbumin-expressing striatal
interneurons after ischemia,” Journal of Clinical Investigation,
vol. 111, no. 8, pp. 1125–1132, 2003.